Author | Karasu, Ebru | dc.contributor.author |
Author | Demmelmaier, Julia | dc.contributor.author |
Author | Kellermann, Stephanie | dc.contributor.author |
Author | Holzmann, Karlheinz | dc.contributor.author |
Author | Köhl, Jörg | dc.contributor.author |
Author | Schmidt, Christoph Q. | dc.contributor.author |
Author | Kalbitz, Miriam | dc.contributor.author |
Author | Gebhard, Florian | dc.contributor.author |
Author | Huber-Lang, Markus | dc.contributor.author |
Author | Halbgebauer, Rebecca | dc.contributor.author |
Date of accession | 2020-12-08T13:51:42Z | dc.date.accessioned |
Available in OPARU since | 2020-12-08T13:51:42Z | dc.date.available |
Date of first publication | 2020-09-02 | dc.date.issued |
Abstract | Initially underestimated as platelet dust, extracellular vesicles are continuously gaining
interest in the field of inflammation. Various studies addressing inflammatory diseases
have shown that microvesicles (MVs) originating from different cell types are systemic
transport vehicles carrying distinct cargoes to modulate immune responses. In this
study, we focused on the clinical setting of multiple trauma, which is characterized by
activation and dysfunction of both, the fluid-phase and the cellular component of innate
immunity. Given the sensitivity of neutrophils for the complement anaphylatoxin C5a,
we hypothesized that increased C5a production induces alterations in MV shedding
of neutrophils resulting in neutrophil dysfunction that fuels posttraumatic inflammation.
In a mono-centered prospective clinical study with polytraumatized patients, we found
significantly increased granulocyte-derived MVs containing the C5a receptor (C5aR1,
CD88) on their surface. This finding was accompanied by a concomitant loss of C5aR1
on granulocytes indicative of an impaired cellular chemotactic and pro-inflammatory
neutrophil functions. Furthermore, in vitro exposure of human neutrophils (from healthy
volunteers) to C5a significantly increased MV shedding and C5aR1 loss on neutrophils,
which could be blocked using the C5aR1 antagonist PMX53. Mechanistic analyses
revealed that the interaction between C5aR1 signaling and the small GTPase Arf6 acts
as a molecular switch for MV shedding. When neutrophil derived, C5a-induced MV
were exposed to a complex ex vivo whole blood model significant pro-inflammatory
properties (NADPH activity, ROS and MPO generation) of the MVs became evident.
C5a-induced MVs activated resting neutrophils and significantly induced IL-6 secretion.
These data suggest a novel role of the C5a-C5aR1 axis: C5a-induced MV shedding
from neutrophils results in decreased C5aR1 surface expression on the one hand, on
the other hand it leads to profound inflammatory signals which likely are both key drivers
of the neutrophil dysfunction which is regularly observed in patients suffering frommultiple
traumatic injuries. | dc.description.abstract |
Language | en | dc.language.iso |
Publisher | Universität Ulm | dc.publisher |
License | CC BY 4.0 International | dc.rights |
Link to license text | https://creativecommons.org/licenses/by/4.0/ | dc.rights.uri |
Keyword | Microvesicle shedding | dc.subject |
Keyword | anaphylatoxin C5a | dc.subject |
Keyword | C5aR1 | dc.subject |
Keyword | neutrophils | dc.subject |
Keyword | Polymorphonuclear neutrophils (PMNs) | dc.subject |
Dewey Decimal Group | DDC 610 / Medicine & health | dc.subject.ddc |
MeSH | Multiple trauma | dc.subject.mesh |
MeSH | Neutrophils | dc.subject.mesh |
Title | Complement C5a induces pro-inflammatory microvesicle shedding in severely injured patients | dc.title |
Resource type | Wissenschaftlicher Artikel | dc.type |
Version | publishedVersion | dc.description.version |
DOI | http://dx.doi.org/10.18725/OPARU-34000 | dc.identifier.doi |
URN | http://nbn-resolving.de/urn:nbn:de:bsz:289-oparu-34062-2 | dc.identifier.urn |
GND | Trauma | dc.subject.gnd |
GND | Neutrophiler Granulozyt | dc.subject.gnd |
Faculty | Medizinische Fakultät | uulm.affiliationGeneral |
Institution | UKU. Institut für Klinische und Experimentelle Trauma-Immunologie | uulm.affiliationSpecific |
Institution | Core Facility Genomics | uulm.affiliationSpecific |
Institution | UKU. Institut für Naturheilkunde und Klinische Pharmakologie | uulm.affiliationSpecific |
Institution | Sonderforschungsbereich 1149 „Gefahrenantwort, Störfaktoren und regeneratives Potential nach akutem Trauma“ | uulm.affiliationSpecific |
Peer review | ja | uulm.peerReview |
DCMI Type | Text | uulm.typeDCMI |
Category | Publikationen | uulm.category |
In cooperation with | Universität zu Lübeck | uulm.cooperation |
In cooperation with | CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER | uulm.cooperation |
DOI of original publication | 10.3389/fimmu.2020.01789 | dc.relation1.doi |
Source - Title of source | Frontiers in Immunology | source.title |
Source - Place of publication | Frontiers Media | source.publisher |
Source - Volume | 11 | source.volume |
Source - Year | 2020 | source.year |
Source - Article number | 1789 | source.articleNumber |
Source - eISSN | 1664-3224 | source.identifier.eissn |
Bibliography | uulm | uulm.bibliographie |
Is Supplemented By | https://www.frontiersin.org/articles/10.3389/fimmu.2020.01789/full#supplementary-material | dc.relation.isSupplementedBy |
xmlui.metadata.uulm.OAfunding | Gefördert vom Ministerium für Wissenschaft, Forschung und Kunst Baden-Württemberg | uulm.OAfunding |
xmlui.metadata.uulm.OAfunding | Open-Access-Förderung durch die Medizinische Fakultät der Universität Ulm | uulm.OAfunding |